Myo‐inositol vs metformin
Adverse events · subfertile women with polycystic ovary syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
4 questions · 4 findings · 2 reviews · Gynaecology and Fertility
No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 50%High 0 · 0%
Metformin vs clomiphene
Gastrointestinal adverse events · women with polycystic ovary syndrome
The review found no eligible studies for this question.
1 finding from 1 review · compare the 2 reviews
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary… 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Metformin vs placebo or no treatment
Gastrointestinal adverse events · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher adverse events (gastrointestinal) per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary… 2017 · Cochrane Headline outcomes onlyOR 4.76 [3.06, 7.41]7 studies · 670 participantsModerate
Metformin combined with clomiphene citrate vs clomiphene
Gastrointestinal adverse events · women with polycystic ovary syndrome
Metformin combined with clomiphene citrate probably leads to higher adverse events (gastrointestinal) per woman compared with clomiphene citrate alone (moderate certainty).
1 finding from 1 review · compare the 2 reviews
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary… 2017 · Cochrane Headline outcomes onlyOR 3.97 [2.59, 6.08]3 studies · 591 participantsModerate